187 related articles for article (PubMed ID: 22556016)
1. B cell homeostasis in chronic hepatitis C virus-related mixed cryoglobulinemia is maintained through naïve B cell apoptosis.
Holz LE; Yoon JC; Raghuraman S; Moir S; Sneller MC; Rehermann B
Hepatology; 2012 Nov; 56(5):1602-10. PubMed ID: 22556016
[TBL] [Abstract][Full Text] [Related]
2. Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis.
Saadoun D; Rosenzwajg M; Landau D; Piette JC; Klatzmann D; Cacoub P
Blood; 2008 Jun; 111(11):5334-41. PubMed ID: 18292291
[TBL] [Abstract][Full Text] [Related]
3. Reply: b-cell frequency in HCV-related mixed cryoglobulinemia.
Holz LE; Yoon JC; Raghuraman S; Moir S; Sneller MC; Rehermann B
Hepatology; 2013 Jul; 58(1):448-9. PubMed ID: 23111813
[No Abstract] [Full Text] [Related]
4. B-cell frequency in hepatitis C virus-related mixed cryoglobulinemia.
Sansonno D; Russi S; Conteduca V; Sansonno L
Hepatology; 2013 Jul; 58(1):448. PubMed ID: 23112004
[No Abstract] [Full Text] [Related]
5. Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset.
Charles ED; Brunetti C; Marukian S; Ritola KD; Talal AH; Marks K; Jacobson IM; Rice CM; Dustin LB
Blood; 2011 May; 117(20):5425-37. PubMed ID: 21421840
[TBL] [Abstract][Full Text] [Related]
6. Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment.
Stasi C; Triboli E; Arena U; Urraro T; Petrarca A; Gragnani L; Laffi G; Zignego AL
J Transl Med; 2014 Jan; 12():21. PubMed ID: 24456582
[TBL] [Abstract][Full Text] [Related]
7. Acute wrist and foot drop associated with hepatitis C virus related mixed cryoglobulinemia: rapid response to treatment with rituximab.
Uppal R; Charles E; Lake-Bakaar G
J Clin Virol; 2010 Jan; 47(1):69-71. PubMed ID: 19892591
[TBL] [Abstract][Full Text] [Related]
8. Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis.
Sène D; Ghillani-Dalbin P; Amoura Z; Musset L; Cacoub P
Arthritis Rheum; 2009 Dec; 60(12):3848-55. PubMed ID: 19950292
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus (HCV) infection of peripheral blood mononuclear cells in patients with type II cryoglobulinemia.
Jabłońska J; Ząbek J; Pawełczyk A; Kubisa N; Fic M; Laskus T; Radkowski M
Hum Immunol; 2013 Dec; 74(12):1559-62. PubMed ID: 23993984
[TBL] [Abstract][Full Text] [Related]
10. Enhanced activation of memory, but not naïve, B cells in chronic hepatitis C virus-infected patients with cryoglobulinemia and advanced liver fibrosis.
Santer DM; Ma MM; Hockman D; Landi A; Tyrrell DL; Houghton M
PLoS One; 2013; 8(6):e68308. PubMed ID: 23840845
[TBL] [Abstract][Full Text] [Related]
11. B cell activating factor (BAFF) in the natural history of chronic hepatitis C virus liver disease and mixed cryoglobulinaemia.
Lake-Bakaar G; Jacobson I; Talal A
Clin Exp Immunol; 2012 Nov; 170(2):231-7. PubMed ID: 23039894
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: a model of infection-driven lymphomagenesis.
Carbonari M; Caprini E; Tedesco T; Mazzetta F; Tocco V; Casato M; Russo G; Fiorilli M
J Immunol; 2005 May; 174(10):6532-9. PubMed ID: 15879157
[TBL] [Abstract][Full Text] [Related]
13. Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.
Saadoun D; Resche Rigon M; Sene D; Terrier B; Karras A; Perard L; Schoindre Y; Coppéré B; Blanc F; Musset L; Piette JC; Rosenzwajg M; Cacoub P
Blood; 2010 Jul; 116(3):326-34; quiz 504-5. PubMed ID: 20439619
[TBL] [Abstract][Full Text] [Related]
14. Long-term remission with rituximab in a patient with severe hepatitis C virus-induced mixed cryoglobulinemia.
Fortea-Ormaechea JI; Lozano-Maya M; Adán-Merino L; Barrio-Antoranz J; Martín-Chavarri S; Corchete-Prats E; Martínez-Acebes E; Aldeguer-Martínez M
Rev Esp Enferm Dig; 2013 Sep; 105(8):490-3. PubMed ID: 24274448
[TBL] [Abstract][Full Text] [Related]
15. The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders.
Landau DA; Rosenzwajg M; Saadoun D; Klatzmann D; Cacoub P
Ann Rheum Dis; 2009 Mar; 68(3):337-44. PubMed ID: 18434450
[TBL] [Abstract][Full Text] [Related]
16. Mixed cryoglobulinemia in hepatitis C patients. GERMIVIC.
Cacoub P; Hausfater P; Musset L; Piette JC
Ann Med Interne (Paris); 2000 Feb; 151(1):20-9. PubMed ID: 10761559
[TBL] [Abstract][Full Text] [Related]
17. Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab.
Petrarca A; Rigacci L; Monti M; Giannini C; Bernardi F; Caini P; Colagrande S; Bosi A; Laffi G; Zignego AL
Dig Liver Dis; 2007 Sep; 39 Suppl 1():S129-33. PubMed ID: 17936214
[TBL] [Abstract][Full Text] [Related]
18. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection.
Agnello V
Springer Semin Immunopathol; 1997; 19(1):111-29. PubMed ID: 9266635
[TBL] [Abstract][Full Text] [Related]
19. Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.
Comarmond C; Garrido M; Pol S; Desbois AC; Costopoulos M; Le Garff-Tavernier M; Si Ahmed SN; Alric L; Fontaine H; Bellier B; Maciejewski A; Rosenzwajg M; Klatzmann D; Musset L; Poynard T; Cacoub P; Saadoun D
Gastroenterology; 2017 Jun; 152(8):2052-2062.e2. PubMed ID: 28274850
[TBL] [Abstract][Full Text] [Related]
20. [Current therapeutic strategies for HCV-associated cryoglobulinemia].
Iannuzzella F; Garini G
Reumatismo; 2008; 60(3):163-73. PubMed ID: 18854876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
